Stevanato Group S.p.A. (STVN) Stock Analysis & Investment Frameworks
Stevanato Group S.p.A. (STVN) stock analysis on Invetso. Review Stevanato Group S.p.A.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Stevanato Group S.p.A. Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: IT
Stevanato Group S.p.A. Key Financial Metrics
- Market Cap: $5.14B
- Revenue: $1.28B
- P/E Ratio: 34.22
- ROE: 8.94%
- ROIC: 6.36%
- Dividend Yield: 0.33%
About Stevanato Group S.p.A.
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A. Investment Frameworks
Invetso analyzes Stevanato Group S.p.A. (STVN) across the following frameworks:
- Stevanato Group S.p.A. 10Y Growth Potential
- Stevanato Group S.p.A. Scenario Analysis
- Stevanato Group S.p.A. Risks & Opportunities
- Stevanato Group S.p.A. Economic Moat
- Stevanato Group S.p.A. Business Model
- Stevanato Group S.p.A. Management
- Stevanato Group S.p.A. SWOT Analysis
- Stevanato Group S.p.A. Porter's 5 Forces
- Stevanato Group S.p.A. PESTLE Analysis
- Stevanato Group S.p.A. ESG Analysis